Birdwatch Archive

Birdwatch Note Rating

2023-05-25 06:16:51 UTC - NOT_HELPFUL

Rated by Participant: 2CDF1ED4C4FDB177F6A176724D1A281256C071DF34B115FFEB38C6CBC9C66850
Participant Details

Original Note:

The report states additional factors to consider, such as production cost, and the fact that the US has funded much of the R&D due to health and national security concerns, affording it a particular role in procurement. More in the original document: https://msfaccess.org/ensuring-access-new-treatments-ebola-virus-disease

All Note Details

Original Tweet

All Information

  • noteId - 1661615040070586368
  • participantId -
  • raterParticipantId - 2CDF1ED4C4FDB177F6A176724D1A281256C071DF34B115FFEB38C6CBC9C66850
  • createdAtMillis - 1684995411529
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 16616150400705863682CDF1ED4C4FDB177F6A176724D1A281256C071DF34B115FFEB38C6CBC9C66850